Goldman Sachs Group Inc Cytek Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,341,752 shares of CTKB stock, worth $6.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,341,752
Previous 1,022,744 31.19%
Holding current value
$6.87 Million
Previous $5.67 Million 53.67%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$4.7 - $7.4 $1.5 Million - $2.36 Million
319,008 Added 31.19%
1,341,752 $8.71 Million
Q3 2024

Nov 14, 2024
SELL
$4.73 - $6.73 $1.58 Million - $2.25 Million
-334,507 Reduced 24.65%
1,022,744 $5.67 Million
Q2 2024

Aug 13, 2024
BUY
$5.3 - $6.91 $4.2 Million - $5.48 Million
793,236 Added 140.64%
1,357,251 $7.57 Million
Q1 2024

May 15, 2024
BUY
$6.29 - $9.15 $7,774 - $11,309
1,236 Added 0.22%
564,015 $3.78 Million
Q4 2023

Feb 13, 2024
BUY
$4.1 - $9.51 $100,138 - $232,272
24,424 Added 4.54%
562,779 $5.13 Million
Q3 2023

May 14, 2024
SELL
$5.52 - $9.5 $134,820 - $232,028
-24,424 Reduced 4.34%
538,355 $2.97 Million
Q3 2023

Nov 14, 2023
SELL
$5.52 - $9.5 $165,820 - $285,380
-30,040 Reduced 5.29%
538,355 $2.97 Million
Q2 2023

May 14, 2024
BUY
$6.69 - $11.99 $2.43 Million - $4.36 Million
363,261 Added 177.08%
568,395 $4.85 Million
Q2 2023

Aug 14, 2023
BUY
$6.69 - $11.99 $2.43 Million - $4.36 Million
363,261 Added 177.08%
568,395 $4.85 Million
Q1 2023

May 14, 2024
SELL
$8.44 - $13.47 $1.32 Million - $2.11 Million
-156,988 Reduced 43.35%
205,134 $1.89 Million
Q1 2023

May 11, 2023
SELL
$8.44 - $13.47 $1.32 Million - $2.11 Million
-156,988 Reduced 43.35%
205,134 $1.89 Million
Q4 2022

May 14, 2024
BUY
$9.71 - $15.86 $2.56 Million - $4.18 Million
263,644 Added 267.72%
362,122 $3.7 Million
Q4 2022

Feb 13, 2023
BUY
$9.71 - $15.86 $2.56 Million - $4.18 Million
263,644 Added 267.72%
362,122 $3.7 Million
Q3 2022

May 14, 2024
BUY
$10.96 - $15.45 $258,502 - $364,403
23,586 Added 31.49%
98,478 $1.45 Million
Q3 2022

Nov 10, 2022
BUY
$10.96 - $15.45 $258,502 - $364,403
23,586 Added 31.49%
98,478 $1.45 Million
Q2 2022

May 14, 2024
SELL
$7.41 - $11.56 $3.62 Million - $5.64 Million
-487,887 Reduced 86.69%
74,892 $803,000
Q2 2022

Aug 15, 2022
SELL
$7.41 - $11.56 $4.26 Million - $6.64 Million
-574,397 Reduced 88.47%
74,892 $803,000
Q1 2022

May 16, 2022
BUY
$9.89 - $17.25 $5.83 Million - $10.2 Million
589,229 Added 981.07%
649,289 $7 Million
Q4 2021

Feb 14, 2022
SELL
$16.14 - $25.04 $149,488 - $231,920
-9,262 Reduced 13.36%
60,060 $980,000
Q3 2021

Nov 10, 2021
BUY
$17.52 - $27.93 $1.21 Million - $1.94 Million
69,322 New
69,322 $1.48 Million

Others Institutions Holding CTKB

# of Institutions
150
Shares Held
74M
Call Options Held
1K
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $689M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email